Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,143 | 98,932 | 99,746 | 92,235 | 68,887 |
| Marketable Securities | 8,096 | 18,942 | 16,376 | 17,170 | 51,607 |
| Receivables | 25,543 | 27,137 | 23,987 | 31,542 | 28,896 |
| Inventories | 3,454 | 3,144 | 2,891 | 3,297 | 3,170 |
| Other current assets | 3,641 | 3,624 | 3,624 | 500 | 477 |
| TOTAL | $146,139 | $159,804 | $159,224 | $158,681 | $166,296 |
| Non-Current Assets | |||||
| PPE Net | 2,481 | 2,659 | 2,859 | 3,085 | 3,304 |
| Intangibles | 74,140 | 76,144 | 78,148 | 39,474 | 40,461 |
| Other Non-Current Assets | 21,460 | 23,088 | 23,583 | 24,289 | 24,844 |
| TOTAL | $98,081 | $101,891 | $104,590 | $66,848 | $68,609 |
| Total Assets | $244,220 | $261,695 | $263,814 | $225,529 | $234,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,286 | 5,714 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 12,076 | 12,528 | 11,767 | 17,268 | 19,183 |
| Accrued Expenses | 82,318 | 94,488 | 78,822 | 69,464 | 69,030 |
| Other current liabilities | 2,481 | 2,496 | 1,085 | 1,000 | N/A |
| TOTAL | $114,255 | $118,197 | $94,526 | $90,467 | $90,837 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,025 | 91,714 | 96,573 | 95,755 | 94,962 |
| Other Non-Current Liabilities | 51,891 | 52,237 | 49,312 | 29,930 | 31,643 |
| TOTAL | $135,916 | $143,951 | $145,885 | $125,685 | $126,605 |
| Total Liabilities | $250,171 | $262,148 | $240,411 | $216,152 | $217,442 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,258 | 39,762 | 39,677 | 39,364 | 39,302 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -1,337,631 | -1,322,637 | -1,291,174 | -1,294,569 | -1,277,636 |
| Other shareholders' equity | 0 | 0 | 1 | 2 | 62 |
| TOTAL | $-5,951 | $-453 | $23,403 | $9,377 | $17,463 |
| Total Liabilities And Equity | $244,220 | $261,695 | $263,814 | $225,529 | $234,905 |